• Ashik. S. S
• Neethu Wilson
• Ajina Kamal
• E Sam Jeevakumar
• Dr. Prasobh G R

Anticoagulant therapy is one of the most important methods of preventing strokes in people with atrial fibrillation (AF).Atrial fibrillation is nothing more than an irregular heartbeat that can lead to blood clotting, stroke, heart failure, and even other heart complications.AF clinical guidelines consistently recommend the long-term oral use of warfarin for the treatment of valvular atrial fibrillation (VAF). However, the risks of blood clots and stroke are associated with different types of non-valvular atrial fibrillation (NVAF).

Warfarin, atrial fibrillation, anticoagulants, vitamin K, clotting factors, CHA2DS2-Vasc, HAS-BLED, stroke, bleeding risk.

"Use Of Vitamin K Antagonist Oral Anticoagulants In Patients With Non Valvular Atrial Fibrillation.", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.9, Issue 6, page no.a328-a333, June-2022, Available :http://www.jetir.org/papers/JETIR2206035.pdf

"Use Of Vitamin K Antagonist Oral Anticoagulants In Patients With Non Valvular Atrial Fibrillation.", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.9, Issue 6, page no. ppa328-a333, June-2022, Available at : http://www.jetir.org/papers/JETIR2206035.pdf